Will We All Become “Drug Addicts” | Lip filler near me costa mesa

With the clear worldwide “obesity epidemic” a major concern for practically everybody, and a major contributor to increased diseases of many kinds and increased sickness care costs, it is understandable that it has also become a major market opportunity for many entrepreneurs. Weight loss products and services have sprung up all over the U.S. for example, and charges that many of they are over-hyped, with only short-term effects soon “reversed” by relapses into old bad habits are rife. If you need more related services or best “Lip filler near me costa mesa” consulting, visit this website today – https://www.belleviemedical.com
Perhaps the biggest market opportunity exists for pharmaceutical manufacturers. What could be better, from a money-making perspective, than coming out with an expensive drug that would be taken by the majority of the population for their entire lives? And there are a number of weight-control drugs already available, working on the body’s processing of fat, on appetite suppressing, energy expenditures, or almost anything that affects body weight and mass.
All will undoubtedly cause side effects, such as the gastro-intestinal problems and occasional embarrassments associated with GlaxoSMithKline’s Alli, and headaches, nausea, insomnia, anxiety and dry mouth effects of Orexigen Therapeutic’s experimental Empatic. [T. Somers “Obesity Drug Shows Promise in Testing” SignOnSanDiego.com July 25, 2023] But given consumers’ almost universal presence for a pill over personal effort to control their weight, all will probably sell well.
When obesity is added to the host of diseases and risks that people will want to avoid, reduce, or eliminate from their lives, including a variety of “disorders” (eating, sleeping, emotional, etc.), “dysfunctions” (erectile, for example), “syndromes” (restless leg, metabolic, etc.), there is almost no limit to the market potential. And this threatens to create the kind of world envisioned in the novel “Brave New World”, where everyone is forever “on drugs”, with all the social and economic consequences thereof.
In the worst case scenario, it may turn out that employers and insurers will be willing to pay enough to make such lasting and widespread “addiction” affordable, once they learn whether they are better off in terms of labor and sickness care cost reductions to pay for such addiction, while consumers decide they are also sufficiently better off in terms of health, appearance, out-of-pocket sickness care costs, etc. I may be a good case example, taking over twenty pills a day for a variety of digestive, physiological, and health protection reasons, though, fortunately, only one is a prescription drug, and it costs only $11 for a 90-day supply.
It may be odd and ironic that we will become dependent on a host of drugs, some OTC and others prescription, some inexpensive and some really challenging to pay for, in pursuit of independence from health problems, particularly in later life. We can hope that the drugs on which we come to depend will be affordable for us as individuals and for payers who help, and will not create so many side effects as to make life unbearable. But we can also choose to make lifestyle change an alternative to addiction in the first place.
There are already programs available to help us make “permanent” lifestyle changes that reverse diseases such as diabetes and heart disease, and may even work with prostate cancer, in the sense of not only controlling the disease, but doing so independently of pharmaceutical dependence. And most of the health risk conditions and behaviors can be reduced or avoided through lifestyle/behavior changes, without using drugs to help, even though there are drugs available to help in most cases.
It may become a personal balancing act that most of us will have to address on our own – how much we are willing to spend on drug dependence to address risks, disorders, dysfunctions, syndromes and diseases. It will certainly require tough decisions on how much we are willing to depend on outside dependence compared to the time and effort costs of do-it-yourself personal health management.
There have often been indications that pharmaceutical drug manufacturers, despite the long use of the term “ethical drug industry” to describe them, have been somewhat unethical, or at least mostly entrepreneurial in promoting use of their products. Examples have included paying other manufacturers not to come out with generic competing products, “bribing” physicians to prescribe them, “medicalizing” problems, questionable advertising to consumers, questionable support of research to support their own or raise questions about competing options, withholding information about side effects, etc.
If we hold with Milton Friedman that the sole duty of publicly held corporations is to deliver returns for their shareholders, we can hardly expect any other pattern of behavior but doing whatever can be gotten away with to promote sales and profits. But the prospect of a nation of drug-dependent consumers, even if they are “healthier” as a result, may be something. And the only preventative for this threat may be consumers taking charge of their own health and health behaviors to prevent being “suckered” into such dependence to make a small number of shareholders richer.
In any case, we will likely all be challenged to balance the total benefits vs. total costs of opting for medication “solutions” to the wide range of problems that we face relative to our health and longevity. There will surely be pharmaceutical and medical solutions available, but there are no medical problems, only problems to which there are medical solutions, among others in most cases. Both preventing and solving such problems will almost always be possible at least partly through our own efforts, in addition to the option of drug dependence. And payers, as well as consumers, themselves, may prefer lower-cost self-management options to lasting dependency.